Bruker ROA 2012-2026 | BRKR
Current and historical return on assets (ROA) values for Bruker (BRKR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Bruker ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2026-03-31 | $-0.04B | $6.29B | -0.56% |
| 2025-12-31 | $-0.02B | $6.24B | -0.35% |
| 2025-09-30 | $-0.02B | $6.13B | -0.38% |
| 2025-06-30 | $0.08B | $6.05B | 1.32% |
| 2025-03-31 | $0.08B | $5.94B | 1.35% |
| 2024-12-31 | $0.11B | $5.58B | 2.04% |
| 2024-09-30 | $0.31B | $5.19B | 5.89% |
| 2024-06-30 | $0.35B | $4.62B | 7.64% |
| 2024-03-31 | $0.40B | $4.11B | 9.79% |
| 2023-12-31 | $0.43B | $3.92B | 10.91% |
| 2023-09-30 | $0.32B | $3.76B | 8.48% |
| 2023-06-30 | $0.32B | $3.64B | 8.76% |
| 2023-03-31 | $0.31B | $3.53B | 8.85% |
| 2022-12-31 | $0.30B | $3.47B | 8.56% |
| 2022-09-30 | $0.28B | $3.48B | 7.93% |
| 2022-06-30 | $0.28B | $3.43B | 8.02% |
| 2022-03-31 | $0.28B | $3.35B | 8.44% |
| 2021-12-31 | $0.28B | $3.23B | 8.62% |
| 2021-09-30 | $0.27B | $3.08B | 8.81% |
| 2021-06-30 | $0.24B | $3.01B | 7.90% |
| 2021-03-31 | $0.20B | $2.98B | 6.85% |
| 2020-12-31 | $0.16B | $2.96B | 5.34% |
| 2020-09-30 | $0.16B | $2.89B | 5.47% |
| 2020-06-30 | $0.17B | $2.76B | 5.98% |
| 2020-03-31 | $0.18B | $2.61B | 6.82% |
| 2019-12-31 | $0.20B | $2.43B | 8.15% |
| 2019-09-30 | $0.21B | $2.27B | 9.12% |
| 2019-06-30 | $0.19B | $2.15B | 8.78% |
| 2019-03-31 | $0.18B | $2.02B | 9.07% |
| 2018-12-31 | $0.18B | $1.91B | 9.35% |
| 2018-09-30 | $0.10B | $1.87B | 5.24% |
| 2018-06-30 | $0.09B | $1.89B | 4.88% |
| 2018-03-31 | $0.08B | $1.91B | 4.39% |
| 2017-12-31 | $0.08B | $1.92B | 4.12% |
| 2017-09-30 | $0.15B | $1.88B | 8.03% |
| 2017-06-30 | $0.16B | $1.84B | 8.75% |
| 2017-03-31 | $0.15B | $1.79B | 8.54% |
| 2016-12-31 | $0.16B | $1.77B | 8.77% |
| 2016-09-30 | $0.15B | $1.75B | 8.41% |
| 2016-06-30 | $0.11B | $1.76B | 6.37% |
| 2016-03-31 | $0.12B | $1.78B | 6.67% |
| 2015-12-31 | $0.10B | $1.79B | 5.69% |
| 2015-09-30 | $0.07B | $1.83B | 3.67% |
| 2015-06-30 | $0.06B | $1.84B | 3.31% |
| 2015-03-31 | $0.06B | $1.89B | 2.91% |
| 2014-12-31 | $0.06B | $1.95B | 2.92% |
| 2014-09-30 | $0.07B | $1.98B | 3.33% |
| 2014-06-30 | $0.08B | $1.99B | 3.87% |
| 2014-03-31 | $0.08B | $1.94B | 4.33% |
| 2013-12-31 | $0.08B | $1.89B | 4.25% |
| 2013-09-30 | $0.06B | $1.85B | 3.13% |
| 2013-06-30 | $0.08B | $1.82B | 4.46% |
| 2013-03-31 | $0.07B | $1.81B | 3.77% |
| 2012-12-31 | $0.08B | $1.80B | 4.33% |
| 2012-09-30 | $0.10B | $1.77B | 5.89% |
| 2012-06-30 | $0.08B | $1.73B | 4.85% |
| 2012-03-31 | $0.10B | $1.72B | 5.58% |
| 2011-12-31 | $0.09B | $1.68B | 5.49% |
| 2011-09-30 | $0.08B | $1.64B | 5.01% |
| 2011-06-30 | $0.09B | $1.54B | 5.79% |
| 2011-03-31 | $0.09B | $1.40B | 6.44% |
| 2010-12-31 | $0.10B | $1.28B | 7.41% |
| 2010-09-30 | $0.11B | $1.19B | 9.26% |
| 2010-06-30 | $0.10B | $1.15B | 8.61% |
| 2010-03-31 | $0.09B | $1.14B | 7.83% |
| 2009-12-31 | $0.08B | $1.11B | 7.29% |
| 2009-09-30 | $0.06B | $1.10B | 5.74% |
| 2009-06-30 | $0.07B | $1.09B | 5.99% |
| 2009-03-31 | $0.07B | $1.11B | 6.69% |
| 2008-12-31 | $0.07B | $1.19B | 5.46% |
| 2008-09-30 | $0.08B | $1.24B | 6.37% |
| 2008-06-30 | $0.09B | $1.09B | 8.04% |
| 2008-03-31 | $0.08B | $0.92B | 9.17% |
| 2007-12-31 | $0.10B | $0.68B | 14.49% |
| 2007-09-30 | $0.13B | $0.46B | 26.97% |
| 2007-06-30 | $0.10B | $0.44B | 22.89% |
| 2007-03-31 | $0.09B | $0.42B | 20.42% |
| 2006-12-31 | $0.08B | $0.40B | 18.84% |
| 2006-09-30 | $0.02B | $0.40B | 4.04% |
| 2006-06-30 | $0.02B | $0.38B | 3.93% |
| 2006-03-31 | $0.01B | $0.37B | 3.21% |
| 2005-12-31 | $0.01B | $0.37B | 2.41% |
| 2005-09-30 | $0.01B | $0.36B | 1.39% |
| 2005-06-30 | $0.00B | $0.36B | 0.00% |
| 2005-03-31 | $0.00B | $0.36B | -1.11% |
| 2004-12-31 | $0.00B | $0.36B | -1.13% |
| 2004-09-30 | $-0.01B | $0.35B | -2.00% |
| 2004-06-30 | $-0.02B | $0.35B | -5.50% |
| 2004-03-31 | $-0.02B | $0.31B | -5.44% |
| 2003-12-31 | $-0.02B | $0.28B | -6.80% |
| 2003-09-30 | $-0.02B | $0.28B | -8.66% |
| 2003-06-30 | $-0.01B | $0.24B | -3.31% |
| 2003-03-31 | $-0.01B | $0.24B | -4.20% |
| 2002-12-31 | $-0.01B | $0.23B | -2.99% |
| 2002-09-30 | $-0.01B | $0.20B | -4.09% |
| 2002-06-30 | $-0.01B | $0.19B | -4.15% |
| 2002-03-31 | $0.00B | $0.19B | -1.59% |
| 2001-12-31 | $0.00B | $0.19B | -1.60% |
| 2001-09-30 | $0.00B | $0.19B | 2.16% |
| 2001-06-30 | $0.00B | $0.18B | 2.20% |
| 2001-03-31 | $0.00B | $0.15B | 1.96% |
| 2000-12-31 | $0.00B | $0.13B | 1.61% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $5.722B | $3.437B |
| Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |
| Harvard Bioscience (HBIO) | United States | $0.019B | 0.00 |